Kyoichi Tamura
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Detection of bimodal survivin expressions in canine cancer types by flow cytometry compared to immunohistochemistry.
Journal: Frontiers in veterinary science
Published: December 28, 2024
Establishment of a BRAF V595E-mutant canine prostate cancer cell line and the antitumor effects of MEK inhibitors against canine prostate cancer.
Journal: Veterinary and comparative oncology
Published: October 31, 2022
Pulmonary solid adenocarcinoma in a dog.
Journal: Journal of comparative pathology
Published: October 28, 2022
A feline case of multiple myeloma treated with bortezomib.
Journal: BMC veterinary research
Published: April 14, 2022
Molecular characterization of canine SHP2 mutants and anti-tumour effect of SHP2 inhibitor, SHP099, in a xenograft mouse model of canine histiocytic sarcoma.
Journal: Veterinary and comparative oncology
Published: May 18, 2021
A canine case of malignant melanoma carrying a KIT c.1725_1733del mutation treated with toceranib: a case report and in vitro analysis.
Journal: BMC veterinary research
Published: December 07, 2020
Commitment toward cell death by activation of autophagy with survivin inhibitor YM155 in two canine squamous cell carcinoma cell lines with high expression of survivin.
Journal: Research in veterinary science
Published: July 20, 2020
Nimustine Treatment of 11 Cases of Canine Histiocytic Sarcoma.
Journal: Journal of the American Animal Hospital Association
Published: March 18, 2020
Big Insulin-like Growth Factor 2-Producing Tumor in a Hypoglycemic Dog.
Journal: Veterinary pathology
Published: March 10, 2020
Genetic alterations of KIT during clonal expansion and subsequent acquisition of resistance to toceranib in a canine mast cell tumor cell line.
Journal: Journal of veterinary pharmacology and therapeutics
Published: May 26, 2019
Canine histiocytic sarcoma cell lines with SHP2 p.Glu76Gln or p.Glu76Ala mutations are sensitive to allosteric SHP2 inhibitor SHP099.
Journal: Veterinary and comparative oncology
Published: April 04, 2019
Establishment and characterization of a cell line from a feline histiocytic sarcoma.
Journal: Veterinary immunology and immunopathology
Published: May 23, 2017
Last Updated: 09/26/2026